Felicia Antohe | Health Professions | Excellence in Research

Dr. Felicia Antohe | Health Professions | Excellence in Research

Head of Proteomics Department at Inst. Cellular Biology and Pathology NS, Romania

Dr. Felicia Antohe, a distinguished researcher and Head of the Proteomics Department at the Institute of Cellular Biology and Pathology, Romanian Academy, is a highly suitable candidate for the Excellence in Research Award. With a Ph.D. in Cellular Biology and over 170 scientific publications, including 90 indexed in Web of Science and over 2,500 citations, she has made significant contributions to biomedical sciences. Her expertise spans proteomics, vascular biology, monoclonal antibody technology, and molecular mechanisms of macromolecular transport. Dr. Antohe has led over 44 national and international research projects, mentored numerous Ph.D. students, and held key roles in prestigious European scientific committees, including as an expert evaluator for EC Framework Programs. Recognized globally with multiple international awards and fellowships, her work has advanced knowledge in atherosclerosis, immune disorders, and endothelial cell biology. Her strong leadership, innovative research, and dedication to scientific excellence make her an exemplary candidate for this honor.

Professional Profile 

Education🎓

Dr. Felicia Antohe holds a robust academic background in the life sciences, beginning with a Master’s degree in Biophysics from the University of Bucharest, Faculty of Physics, completed between 1972 and 1977. She later pursued her doctoral studies at the Romanian Academy’s Institute of Cellular Biology and Pathology (IBPC N. Simionescu), where she earned a Ph.D. in Cellular Biology between 1985 and 1994. In 2000, she was accredited as a Ph.D. Coordinator in Cellular Biology by the Romanian Academy and the Ministry of Education and Research. Her education has been complemented by extensive international training and research fellowships at prestigious institutions such as McGill University (Canada), University of Alberta (Canada), Max Planck Institute (Germany), and Université René Descartes (France), among others. This rich educational foundation has equipped Dr. Antohe with interdisciplinary expertise spanning biophysics, molecular biology, immunology, and proteomics, laying the groundwork for her prolific and impactful scientific career.

Professional Experience📝

Dr. Felicia Antohe has an extensive and distinguished professional background in biomedical research, currently serving as Head of the Proteomics Department at the Institute of Cellular Biology and Pathology “N. Simionescu” of the Romanian Academy. She has also led the Monoclonal Antibody Laboratory and serves as a Ph.D. Coordinator in Cellular Biology. With over four decades of experience, she has acted as Principal Investigator on more than 44 nationally and internationally funded research projects and has mentored numerous Ph.D. and postgraduate students. Her international experience includes research fellowships and visiting scientist roles at top institutions such as McGill University, University of Alberta, Max Planck Institute, and Université René Descartes. She has served as an expert evaluator for EU Framework Programs (FP6, FP7), contributed to national research councils, and held leadership roles in international scientific networks like COST and the Central and Eastern European Proteomic Conferences. Her work integrates academic leadership with pioneering research.

Research Interest🔎

Dr. Felicia Antohe’s research interests lie at the intersection of cellular biology, molecular biology, and biomedical sciences, with a particular focus on the vascular endothelium. Her work explores the molecular mechanisms of macromolecule transport across endothelial cells, including transcytosis and endocytosis, in both healthy and pathological conditions such as atherosclerosis, diabetes, and immune disorders. She is deeply engaged in the study of membrane microdomains—lipid rafts and caveolae—and their structural and functional roles in cellular signaling and transport. Dr. Antohe is also an expert in proteomics, utilizing mass spectrometry and bioinformatics to analyze endothelial cell proteins in health and disease. Her research extends into the biotechnology of monoclonal and polyclonal antibodies for diagnostic and therapeutic applications. With a strong foundation in immunochemistry, molecular diagnostics, and nanostructured materials, her interdisciplinary investigations contribute to advancing biomedical knowledge and improving clinical strategies for vascular and systemic inflammatory diseases.

Award and Honor🏆

Dr. Felicia Antohe has received numerous prestigious awards and honors in recognition of her outstanding contributions to biomedical research. Internationally, she was awarded the EURESCO Prize for her work on membrane dynamics, and received the BIO-RAD Laboratories Prize for valuable scientific contributions. Her research has been recognized with the IIIrd Award at the International Congress of Medical Sciences in Bulgaria, and the Best Poster Award at the 8th International Conference on Vascular Endothelium in Greece. She has also earned fellowships, including the ESF grant for EURESCO Conferences and a Summer School Fellowship in Scotland. Nationally, she received the esteemed Emil Racoviță Prize from the Romanian Academy and eight other awards from institutions such as the University of Bucharest and CNCSIS. Additionally, she has been an invited speaker at numerous global conferences and authored monographs featured in over 1,900 international libraries, cementing her influence in the scientific community.

Research Skill🔬

Dr. Felicia Antohe possesses an exceptional array of research skills, developed through decades of pioneering work in cellular biology and proteomics. Her technical expertise encompasses a broad range of advanced methodologies, including immunological techniques such as monoclonal antibody production, FACS, ELISA, and immunocytochemistry. She is highly proficient in molecular biology tools, including PCR, RT-qPCR, in situ hybridization, and plasmid transfection. Dr. Antohe is also skilled in cell biology practices like cell culture, fluorescence and electron microscopy, and animal modeling. Her proteomics capabilities include 1D and 2D SDS-PAGE, protein radio-labeling, scintillation and gamma counting, and mass spectrometry, coupled with strong bioinformatics analysis. She has also applied her knowledge to complex systems such as lipid rafts, transcytosis, and membrane receptor function. In addition to hands-on techniques, she excels in mentoring young scientists and PhD students, reflecting her strong leadership in research training and laboratory development.

Conclusion💡

Dr. Felicia Antohe is highly suitable for an Excellence in Research Award, particularly one recognizing:

  • Lifetime achievements

  • Biomedical innovation

  • Mentorship

  • Leadership in research ecosystems

Her academic depth, scientific rigor, and institutional leadership align strongly with the core mission of such an award. While certain modern metrics (e.g., recent societal impact or innovation transfer) could be elaborated more, these are secondary when weighed against the breadth and depth of her contributions.

Publications Top Noted✍️

  • Firan M., Bawdon R., Radu C., Ober R.J., Eaken D., Antohe F., Ghetie V., et al. (2001). The MHC class I-related receptor, FcRn, plays an essential role in the maternofetal transfer of γ-globulin in humans. International Immunology, 13(8), 993–1002.
    📌 Citations: 404

  • Borvak J., Richardson J., Medesan C., Antohe F., Radu C., Simionescu M., et al. (1998). Functional expression of the MHC class I-related receptor, FcRn, in endothelial cells of mice. International Immunology, 10(9), 1289–1298.
    📌 Citations: 308

  • Simionescu M., Gafencu A., Antohe F. (2002). Transcytosis of plasma macromolecules in endothelial cells: a cell biological survey. Microscopy Research and Technique, 57(5), 269–288.
    📌 Citations: 272

  • Antohe F., Rădulescu L., Gafencu A., Gheţie V., Simionescu M. (2001). Expression of functionally active FcRn and the differentiated bidirectional transport of IgG in human placental endothelial cells. Human Immunology, 62(2), 93–105.
    📌 Citations: 204

  • Van Gool A., Corrales F., Čolović M., Krstić D., Oliver-Martos B., Antohe F., et al. (2020). Analytical techniques for multiplex analysis of protein biomarkers. Expert Review of Proteomics, 17(4), 257–273.
    📌 Citations: 95

  • Simionescu M., Antohe F. (2006). Functional ultrastructure of the vascular endothelium: changes in various pathologies. In: The Vascular Endothelium I, pp. 41–69.
    📌 Citations: 90

  • Manduteanu I., Voinea M., Antohe F., Dragomir E., Capraru M., Radulescu L., et al. (2003). Effect of enoxaparin on high glucose-induced activation of endothelial cells. European Journal of Pharmacology, 477(3), 269–276.
    📌 Citations: 85

  • Lixandru B.E., Cotar A.I., Straut M., Usein C.R., Cristea D., Ciontea S., Antohe F., et al. (2015). Carbapenemase-Producing Klebsiella pneumoniae in Romania: A Six-Month Survey. PLoS ONE, 10(11), e0143214.
    📌 Citations: 66

  • Antohe F., Dobrila L., Heltianu C., Simionescu N., Simionescu M. (1993). Albumin-binding proteins function in the receptor-mediated binding and transcytosis of albumin across cultured endothelial cells. European Journal of Cell Biology, 60(2), 268–275.
    📌 Citations: 66

  • Haraba R., Suica V.I., Uyy E., Ivan L., Antohe F. (2011). Hyperlipidemia stimulates the extracellular release of the nuclear high mobility group box 1 protein. Cell and Tissue Research, 346, 361–368.
    📌 Citations: 53

Xiaoping Ren | Health Professions | Best Innovation Award

Prof. Dr. Xiaoping Ren | Health Professions | Best Innovation Award

Professor at Lisnom Health, CA, United States

Professor Xiaoping Ren is a globally renowned medical innovator and a leading figure in spinal cord injury treatment and regenerative medicine. As the Chief Scientist of the Global Initiative for the Cure of Paraplegia and Chief Scientific Officer of Lisnom Health, USA, he has pioneered groundbreaking procedures such as the world’s first cephalosomatic anastomosis (head-body transplant) in a mouse model and developed the revolutionary Spinal Cord Fusion (SCF/GEMINI Protocol) using PEG cocktails. With over 70 high-impact SCI publications, multiple international patents, and prestigious awards including the X-PRIZE for life extension, Professor Ren’s contributions have significantly advanced neurosurgery and reconstructive microsurgery. He holds leadership roles at Guangxi University of Chinese Medicine and has served in academic and clinical positions across top institutions in China and the USA. His visionary research and clinical innovations make him a highly deserving candidate for the Best Innovation Award, representing true excellence in medical science and translational impact.

Professional Profile 

Education🎓

Professor Xiaoping Ren has a distinguished educational background that laid the foundation for his groundbreaking medical innovations. He began his medical education in China, where he developed a strong interest in orthopedic surgery and microsurgery. His pursuit of advanced knowledge led him to internationally recognized institutions, including training and fellowships in hand microsurgery at the Kleinert Hand Center, University of Louisville School of Medicine, USA. Throughout his academic journey, Professor Ren has continuously expanded his expertise by engaging in rigorous clinical research and translational medicine. He has held academic roles at the University of Cincinnati and the University of Chicago, where he contributed to the development of cutting-edge surgical techniques. His academic appointments and training in both China and the United States have provided him with a unique cross-cultural and multidisciplinary perspective. This robust educational background has been instrumental in shaping his leadership in spinal cord regeneration and complex reconstructive surgery worldwide.

Professional Experience📝

Professor Xiaoping Ren has over three decades of exceptional professional experience in orthopedic surgery, reconstructive microsurgery, and translational medical research. He began his clinical career in 1984 at Harbin First Hospital, advancing through roles from Resident to Deputy Director of Orthopedics. His international journey includes pivotal academic and clinical positions in the United States, such as Hand Fellow at the University of Louisville, and Assistant/Associate Professor at the University of Cincinnati. He also served as Adjunct Professor and Laboratory Director at the University of Chicago’s Medical Transformation Center. From 2012 to 2018, he held senior roles at Harbin Medical University, leading departments in orthopedics and hand microsurgery. Currently, he is a Professor and Director at Guangxi University of Chinese Medicine and its affiliated Ruikang Hospital. Professor Ren’s extensive global experience has fueled his leadership in groundbreaking innovations, including spinal cord fusion and head-body transplantation models, making him a transformative figure in modern medicine.

Research Interest🔎

Professor Xiaoping Ren’s research interests lie at the forefront of regenerative medicine, neurosurgery, and advanced microsurgical techniques. His primary focus is on spinal cord injury repair and functional restoration through innovative approaches such as the Spinal Cord Fusion (SCF/GEMINI Protocol) using PEG-based cocktails. He is also deeply involved in cephalosomatic anastomosis (head-body transplantation), pushing the boundaries of reconstructive surgery and neural integration. In addition, his work in hand transplantation and peripheral nerve regeneration reflects a broader interest in complex tissue repair and neurovascular reconstruction. Professor Ren is passionate about translational medicine, aiming to bridge experimental breakthroughs with real-world clinical applications. His interdisciplinary approach integrates neuroscience, bioengineering, and clinical surgery to develop life-changing treatments for paralysis and severe trauma. Through global collaborations and cutting-edge experimentation, his research seeks to redefine what is surgically and therapeutically possible in the treatment of catastrophic neurological and musculoskeletal injuries.

Award and Honor🏆

Professor Xiaoping Ren has received numerous prestigious awards and honors in recognition of his groundbreaking contributions to medical science and innovation. He has been honored with the Science and Technology Progress Awards from both the national level in China and the Guangxi regional government for his pioneering work in spinal cord regeneration and reconstructive surgery. Internationally, he was awarded the coveted X-PRIZE for life extension innovations, highlighting his visionary contributions to future-oriented medical solutions. Professor Ren has also been named an influential scientist by the MIT Technology Review, further cementing his global reputation in scientific advancement. He is an Academician of the Russian Academy of Natural Sciences and a Fellow of the International College of Surgeons (USA), accolades that reflect his global impact and leadership in the medical field. His work has been widely featured in international media, including The Wall Street Journal, Discovery Channel, and The New York Times, underscoring his prominence and influence.

Research Skill🔬

Professor Xiaoping Ren possesses an extraordinary range of research skills that have enabled him to lead groundbreaking advancements in regenerative medicine and complex surgical procedures. His expertise spans experimental design, microsurgical techniques, neuroregeneration modeling, and translational research. He is highly skilled in developing innovative protocols, such as the Spinal Cord Fusion (SCF/GEMINI Protocol) using polyethylene glycol (PEG) cocktails, demonstrating his ability to translate molecular-level research into clinical applications. Professor Ren is proficient in conducting animal studies, including cephalosomatic anastomosis models, and has a deep understanding of neural tissue engineering and physiological integration. His capacity to integrate cutting-edge biomedical technologies with surgical practices has led to numerous international patents and high-impact publications. Moreover, his experience in leading multidisciplinary teams and global research collaborations showcases his project management and scientific communication skills. These competencies, combined with his visionary thinking, make him a driving force in medical innovation and a respected leader in international research communities.

Conclusion💡

Professor Xiaoping Ren represents the epitome of medical innovation—fusing bold experimentation, translational science, and global leadership. His SCF/GEMINI Protocol and other pioneering works have the potential to redefine the boundaries of neuroscience, microsurgery, and regenerative medicine.

Publications Top Noted✍️

  • Ren XP, Wu J, Wang X, Sartor MA, Qian J, Jones K, Nicolaou P, et al.
    2009655 citations
    Title: MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20
    Journal: Circulation 119 (17), 2357–2366

  • Wang X, Zhang X, Ren XP, Chen J, Liu H, Yang J, Medvedovic M, Hu Z, et al.
    2010393 citations
    Title: MicroRNA-494 targeting both proapoptotic and antiapoptotic proteins protects against ischemia/reperfusion-induced cardiac injury
    Journal: Circulation 122 (13), 1308–1318

  • Diwan A, Krenz M, Syed FM, Wansapura J, Ren X, Koesters AG, Li H, et al.
    2007368 citations
    Title: Inhibition of ischemic cardiomyocyte apoptosis through targeted ablation of Bnip3 restrains postinfarction remodeling in mice
    Journal: The Journal of Clinical Investigation 117 (10), 2825–2833

  • Fan GC, Ren X, Qian J, Yuan Q, Nicolaou P, Wang Y, Jones WK, Chu G, et al.
    2005273 citations
    Title: Novel cardioprotective role of a small heat-shock protein, Hsp20, against ischemia/reperfusion injury
    Journal: Circulation 111 (14), 1792–1799

  • Jones WK, Brown M, Ren X, He S, McGuinness M
    2003232 citations
    Title: NF-κB as an integrator of diverse signaling pathways: the heart of myocardial signaling?
    Journal: Cardiovascular Toxicology 3, 229–253

  • Francois CG, Breidenbach WC, Maldonado C, Kakoulidis TP, Hodges A, et al.
    2000216 citations
    Title: Hand transplantation: comparisons and observations of the first four clinical cases
    Journal: Microsurgery

  • Luther KM, Haar L, McGuinness M, Wang Y, Lynch IV TL, Phan A, Song Y, et al.
    2018201 citations
    Title: Exosomal miR-21a-5p mediates cardioprotection by mesenchymal stem cells
    Journal: Journal of Molecular and Cellular Cardiology 119, 125–137

  • Fan GC, Zhou X, Wang X, Song G, Qian J, Nicolaou P, Chen G, Ren X, et al.
    2008201 citations
    Title: Heat shock protein 20 interacting with phosphorylated Akt reduces doxorubicin-triggered oxidative stress and cardiotoxicity
    Journal: Circulation Research 103 (11), 1270–1279

  • Jones WK, Fan GC, Liao S, Zhang JM, Wang Y, Weintraub NL, et al.
    2009198 citations
    Title: Peripheral nociception associated with surgical incision elicits remote nonischemic cardioprotection via neurogenic activation of protein kinase C signaling
    Journal: Circulation 120 (11_suppl_1), S1–S9

  • Wang X, Zhu H, Zhang X, Liu Y, Chen J, Medvedovic M, Li H, Weiss MJ, et al.
    2012166 citations
    Title: Loss of the miR-144/451 cluster impairs ischaemic preconditioning-mediated cardioprotection by targeting Rac-1
    Journal: Cardiovascular Research 94 (2), 379–390

  • Jones Jr JW, Üstüner ET, Zdichavsky M, Edelstein J, Ren X, Maldonado C, et al.
    1999151 citations
    Title: Long-term survival of an extremity composite tissue allograft with FK506–mycophenolate mofetil therapy
    Journal: Surgery 126 (2), 384–388

  • Qian J, Ren X, Wang X, Zhang P, Jones WK, Molkentin JD, Fan GC, et al.
    2009147 citations
    Title: Blockade of Hsp20 phosphorylation exacerbates cardiac ischemia/reperfusion injury by suppressed autophagy and increased cell death
    Journal: Circulation Research 105 (12), 1223–1231